Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumabReport as inadecuate




Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab - Download this document for free, or read online. Document in PDF available to download.

Journal for ImmunoTherapy of Cancer

, 3:P197

First Online: 04 November 2015DOI: 10.1186-2051-1426-3-S2-P197

Cite this article as: Sznol, M., Fishman, M., Escudier, B. et al. j. immunotherapy cancer 2015 3Suppl 2: P197. doi:10.1186-2051-1426-3-S2-P197 Download fulltext PDF



Author: Mario Sznol - Mayer Fishman - Bernard Escudier - David F McDermott - Harriet Kluger - Walter M Stadler - Jose Perez-Graci

Source: https://link.springer.com/







Related documents